BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24938706)

  • 1. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
    Jin J; Xie L; Xie CH; Zhou YF
    Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
    Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
    Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells].
    Meng CF; Zhu XJ; Dai DQ; Peng G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
    Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
    Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    Kupcinskaite-Noreikiene R; Ugenskiene R; Noreika A; Rudzianskas V; Gedminaite J; Skieceviciene J; Juozaityte E
    BMC Cancer; 2016 Jan; 16():40. PubMed ID: 26810771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
    Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation of the P16, MGMT, and hMLH1 genes in combination with the methylenetetrahydrofolate reductase C677T genetic polymorphism and folate intake in gastric cancer.
    Lin J; Zeng RM; Li RN; Cao WH
    Genet Mol Res; 2014 Mar; 13(1):2060-8. PubMed ID: 24737431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
    Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
    Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
    Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):978-81. PubMed ID: 17650424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
    Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
    Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
    World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.